David Younger | Co-Founder And Chief Executive Officer
A-Alpha Bio

David Younger is the Co-Founder and CEO of A-Alpha Bio, a Seattle-based biotechnology company applying synthetic biology, protein engineering, and machine learning to understand and engineer protein-protein interactions. The company's AlphaSeq platform enables quantitative measurements of millions of protein-protein interactions - data which are then used to train predictive models and aid in the discovery of therapeutic antibodies and molecular glues. David invented AlphaSeq with Scientific Advisors David Baker and Eric Klavins at the University of Washington, where he earned his PhD in Bioengineering. David's technical expertise spans synthetic biology, protein engineering, and Next Generation Sequencing assay development.